Speaker

Frank A Anania, MD, FAASLD, FACP, AGAF

U.S. Food and Drug Adminstration
Frank A Anania, MD, FAASLD, FACP, AGAF

Biography

Frank Anania is currently the Director of the Division of Hepatology and Nutrition at the US Food and Drug Administration (FDA) in Washington, DC. He has been with the Agency for over seven years. Prior to coming to the FDA, he was the R. Bruce Logue Chair of the Division of Digestive Diseases and Professor of Medicine at Emory University School of Medicine in Atlanta.

Sessions

8:00 AM - 10:30 AM
Nov 09 2025
Washington, D.C.

Global Consensus Endpoints for Clinical Trials: MetALD (Joint with EASL), ALD, MASLD, and Alpha-1 Antitrypsin Deficiency

Aleksander A. Krag, MD, PhD, Presenter
Mazen Noureddin, MD, MHSc, Presenter
Juan Pablo Arab, MD, FRCPC, Presenter
Debbie L Shawcross, BSc, MBBS, PhD, FRCP, Presenter
Mary E. Rinella, MD, FAASLD, Presenter
Gyongyi Szabo, MD, PhD, FAASLD, Presenter
Rohit Loomba, MD, MHSc, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Global
MASLD
9:45 AM - 10:45 AM
Nov 10 2025
Washington, D.C.

Breaking News in MASH: FDA's Pathway for NIT-Driven Endpoints

Frank A Anania, MD, FAASLD, FACP, AGAF, Presenter
Mary E. Rinella, MD, FAASLD, Presenter
MASLD